Monoclonal Antibodies

Monoclonal antibodies (mAbs) are antibodies with monovalent activity that can target a single epitope, which results in high specificity and low cross-reactivity.
Fortis Life Sciences® has applied B-cell sorting and recombinant DNA technology to our unparalleled on-site manufacturing process to deliver high quality recombinant monoclonal antibodies (mAbs). Via our powerful screening process, we are able to search through thousands of clones to find the very best antibody candidates and submit them to rigorous testing to provide you with confidence in your results.
Recombinant antibodies overcome the limitations of other methods of antibody manufacturing to give you the highest level of consistency between batches, unrivaled reproducibility, confirmed specificity, and a guaranteed long-term supply.
Monoclonal Antibodies (mAbs) - Fortis
Monoclonal antibodies can also be produced by immunizing animals with antigens to produce B-cells, which are then fused with myeloma cells to produce hybridomas that are used for ongoing monoclonal antibody production. Fortis Life Sciences has a catalog of hybridoma-derived antibodies that have been produced and validated in-house for numerous immunoassay applications.
Our recombinant and hybridoma-derived monoclonal antibodies are available in a variety of host species, and can be used for IHC/IF/ICC, ELISA, Western blotting, flow cytometry and more. Our monoclonal antibodies can also be customized to your precise needs. To inquire about our monoclonal antibodies, or to discuss custom antibody conjugation or custom orders, please get in touch with our expert team.